Evidence map›Paper›PMID 25018919›Full record

ArticleKidney international supplements2012

Section 3: Prevention and Treatment of AKI.

Abstract read
In one paragraph

Article in Kidney international supplements, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Biomarkers of acute kidney injury: time to learn from implementations.Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine · 2021
    Article
  9. Article
  10. Low-Level Proteinuria in Systemic Lupus Erythematosus.Kidney international reports · 2020
    Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. MicroRNA-709 Mediates Acute Tubular Injury through Effects on Mitochondrial Function.Journal of the American Society of Nephrology : JASN · 2018
    Article
  17. Article
  18. Review
  19. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2016
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

0 authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID25018919
PMCPMC4089747

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.